Arrivano nuove specialità medicinali: Fadezin, Gramigut, Lifog, Lytgobi, Omjjara, Pepaxti, Vyvgart oltre a 13 nuovi farmaci equivalenti
Nuove specialità medicinali
FADEZIN 20 cpr riv 25 mg prometazina cloridrato
S.F. GROUP AIC:050010014 14,00€ Cnn/RR in commercio dal:27/01/2025
GRAMIGUT collirio 30 monod 3 mg/ml 0,5 ml ofloxacina
OMNIVISION AIC:050683022 14,90€ Cnn/RR in commercio dal:29/01/2025
LIFOG collirio 7,5 ml 50 mcg/ml con contagocce latanoprost
ALFA INTES AIC:049747025 28,05€ A/RR in commercio dal:03/02/2025
LYTGOBI 21 cpr riv 4 mg futibatinib
TAIHO PHARMA AIC:050756016 3.599,26€ H/RNRL in commercio dal:01/02/2025
LYTGOBI 28 cpr riv 4 mg futibatinib
TAIHO PHARMA AIC:050756028 3.599,26€ H/RNRL in commercio dal:01/02/2025
OMJJARA 30 cpr riv 100 mg flacone momelotinib dicloridrato
GLAXOSMITHKLINE AIC:050977014 7.144,00€ H/RNRL in commercio dal:31/01/2025
OMJJARA 30 cpr riv 150 mg flacone momelotinib dicloridrato
GLAXOSMITHKLINE AIC:050977026 7.144,00€ H/RNRL in commercio dal:31/01/2025
OMJJARA 30 cpr riv 200 mg flacone momelotinib dicloridrato
GLAXOSMITHKLINE AIC:050977038 7.144,00€ H/RNRL in commercio dal:31/01/2025
PEPAXTI INFUS EV 20 mg 1 flaconcino polv melfalan flufenamide cloridrato
ONCOPEPTIDES AIC:050299015 8117,7€ H/OSP in commercio dal:03/02/2025
VYVGART 1 flaconcino SC 1.000 mg 180 mg/ml efgartigimod alfa
ARGENX AIC:050235023 23.003,44€ H/RNRL in commercio dal:31/01/2025
Nuovi farmaci equivalenti
AMLODIPINA E VALSARTAN KRKA PHARMA 28 cpr riv 5 mg + 80 mg amlodipina besilato/valsartan
KRKA AIC:044288013 7,47€ A/RR in commercio dal:28/01/2025
BRUCORTEN 20 cpr 10 mg prednisone
BRUNO FARMACEUTICI AIC:049645056 12,50€ Cnn/RR in commercio dal:31/01/2025
BRUCORTEN 20 cpr 2,5 mg prednisone
BRUNO FARMACEUTICI AIC:049645031 5,00€ Cnn/RR in commercio dal:30/01/2025
BRUCORTEN 20 cpr 25 mg prednisone
BRUNO FARMACEUTICI AIC:049645070 25,00€ Cnn/RR in commercio dal:31/01/2025
BRUCORTEN 20 cpr 30 mg prednisone
BRUNO FARMACEUTICI AIC:049645094 30,00€ Cnn/RR in commercio dal:31/01/2025
BRUCORTEN 20 cpr 5 mg prednisone
BRUNO FARMACEUTICI AIC:049645017 7,50€ Cnn/RR in commercio dal:31/01/2025
ERIBULINA ZENTIVA 1 flaconcino EV 2 ml 0,44 mg/ml eribulina mesilato
ZENTIVA AIC:051021018 417,05€ H/OSP in commercio dal:29/01/2025
FINGOLIMOD EG 28 cps 0,5 mg fingolimod cloridrato
EG AIC:047973096 804,33€ A/RRL in commercio dal:30/01/2025
FINGOLIMOD TILLOMED 28×1 cps 0,5 mg fingolimod cloridrato
TILLOMED AIC:049299023 804,33€ A/RRL in commercio dal:31/01/2025
POMALIDOMIDE ZENTIVA 21 cps 1 mg pomalidomide
ZENTIVA AIC:051363048 9.780,88€ H/RNRL in commercio dal:31/01/2025
POMALIDOMIDE ZENTIVA 21 cps 2 mg pomalidomide
ZENTIVA AIC:051363087 9.780,88€ H/RNRL in commercio dal:31/01/2025
POMALIDOMIDE ZENTIVA 21 cps 3 mg pomalidomide
ZENTIVA AIC:051363125 9.780,88€ H/RNRL in commercio dal:31/01/2025
POMALIDOMIDE ZENTIVA 21 cps 4 mg pomalidomide
ZENTIVA AIC:051363164 9.780,88€ H/RNRL in commercio dal:31/01/2025